Discontinued — last reported Q4 '25
Amgen Other Investing decreased by 80.0% to $4.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 88.9%, from $36.00M to $4.00M.
Generally neutral, but large fluctuations may indicate non-recurring events or specific financial adjustments that warrant further investigation.
This metric aggregates miscellaneous cash inflows and outflows related to investing activities that do not fit into stan...
Usually a small component of total investing cash flow; peers report similar miscellaneous items based on specific accounting treatments.
other_investing| Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $169.00M | -$47.00M | -$14.00M | $120.00M | -$159.00M | -$28.00M | -$59.00M | $0.00 | -$151.00M | -$13.00M | -$21.00M | -$47.00M | $36.00M | $20.00M | $4.00M |
| QoQ Change | — | -127.8% | +70.2% | +957.1% | -232.5% | +82.4% | -110.7% | +100.0% | — | +91.4% | -61.5% | -123.8% | +176.6% | -44.4% | -80.0% |
| YoY Change | — | — | — | -29.0% | — | +40.4% | -321.4% | -100.0% | +5.0% | +53.6% | +64.4% | — | +376.9% | +195.2% | -88.9% |